Market Overview

Piper Jaffray Downgrades Vitamin Shoppe To Neutral

Related VSI
Vitamin Shoppe Downgraded At JPMorgan As Industry Loses Muscle
Barclays Shrugs At Food & Staples Sector, Interest Piqued By Just 3 Names
Vitamin Shoppe: Close To 6 Year Lows With Potential Upside (Seeking Alpha)

Analysts at Piper Jaffray downgraded Vitamin Shoppe (NYSE: VSI) from Overweight to Neutral.

The target price for Vitamin Shoppe has been lowered from $45 to $44.

Vitamin Shoppe shares have gained 2.69% over the past 52 weeks, while the S&P 500 index has jumped 16.68% in the same period.

Vitamin Shoppe's shares fell 1.50% to close at $45.40 yesterday.

Latest Ratings for VSI

Oct 2016JP MorganDowngradesOverweightNeutral
Sep 2016BarclaysInitiates Coverage onEqual-Weight
Apr 2016WedbushInitiates Coverage onOutperform

View More Analyst Ratings for VSI
View the Latest Analyst Ratings

Posted-In: Piper JaffrayDowngrades Analyst Ratings


Related Articles (VSI)

View Comments and Join the Discussion!